Rena Denoncourt is a Director of Market Access at Alnylam Pharmaceuticals. She joined Alnylam in 2007 and served in roles of increasing responsibility in the Business Planning and Program Management function for seven years. In 2014, she transitioned into a market access role to drive innovative commercial strategies and the implementation of novel market access initiatives across the Alnylam portfolio of transformative RNAi therapeutics. Prior to Alnylam, Ms. Denoncourt held a position as Patent and Licensing Associate in the Intellectual Property Office at the Whitehead Institute for Biomedical Research. Ms. Denoncourt received a Masters of Business Administration from the MIT Sloan School of Management and a Bachelor of Science in Biology from the Massachusetts Institute of Technology.